bookmark

α-Lipoic Acid as Adjunctive Treatment for Schizophrenia: An.Open-label Trial.. : Journal of Clinical Psychopharmacology


Description

Accumulating evidence suggests an involvement of oxidative stress in the pathophysiology of schizophrenia. This offers a hypothesis-derived therapeutic approach to hinder oxidative damage and its clinical sequelae. α-Lipoic acid (ALA) is a powerful natural antioxidant indicated to treat diabetic neuropathy. SSSFT staff can use the OVID link, or you can request a copy of this article by replying to this email. Please ensure you are clear which article you are requesting.

Preview

Tags

Users

  • @sssftlibrary

Comments and Reviews